Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EFS of the DUO System for Tricuspid Regurgitation

NCT: NCT05913908 · RECRUITING

NCT IDNCT05913908
StatusRECRUITING
Start Date2024-08-13
Completion2029-10

Brief Summary

The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).

Frequently Asked Questions

What is EFS of the DUO System for Tricuspid Regurgitation?

EFS of the DUO System for Tricuspid Regurgitation is a clinical trial registered under NCT05913908. Current status: RECRUITING.

What is the status of NCT05913908?

The current status of NCT05913908 (EFS of the DUO System for Tricuspid Regurgitation) is: RECRUITING.

When did EFS of the DUO System for Tricuspid Regurgitation start?

EFS of the DUO System for Tricuspid Regurgitation started on 2024-08-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑